icolung
icometrix
Product specifications |
Information source:
Vendor
Last updated: June 18, 2020 |
General | |
---|---|
Product name | icolung |
Company | icometrix |
Subspeciality | Chest |
Modality | CT |
Disease targeted | COVID-19 |
Key-features | Quantification of lung involvement, total and lobular, lesion classification |
Suggested use | During: perception aid (prompting all abnormalities/results/heatmaps), report suggestion |
Data characteristics | |
Population | all non-contrast chest CT images |
Input | non-contrast chest CT image |
Input format | DICOM |
Output | Color-coded segmentation overlays, report with quantification of lung involvement. |
Output format | DICOM |
Technology | |
Integration | Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform |
Deployment | Cloud-based |
Trigger for analysis | Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc. |
Processing time | 1 - 10 minutes |
Certification | |
CE
|
Certified,
Class I
, MDD
|
FDA
|
No or not yet |
Market presence | |
On market since | 04-2020 |
Distribution channels | Siemens Teamplay, Calantic |
Countries present (clinical, non-research use) | 17 |
Paying clinical customers (institutes) | 75 |
Research/test users (institutes) | 20 |
Pricing | |
Pricing model | Pro bono |
Based on | Public need |
Evidence | |
Peer reviewed papers on performance | |
Non-peer reviewed papers on performance | |
Other relevant papers | https://icometrix.com/resources/the-role-of-imaging-ai--and--ct-in-covid19 |